Yissum is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem
Yissum is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem. Founded 1964 in Jerusalem, Yerushalayim, Israel, this government and university program invests in private equity and early stage ventures. It typically funds Series A, venture rounds, private equity rounds and Series B rounds. Its portfolio companies include Agrinnovate India, Avraham Pharmaceuticals and Chiasma. Yissum’s business partners include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum Technology Transfer Company of the Hebrew University has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.
AYissum is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem
Yissum Research Development is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem. Founded 1964 in Jerusalem, Yerushalayim, Israel, this government and university program invests in private equity and early stage ventures. It typically funds Series A, venture rounds, private equity rounds and Series B rounds. Its portfolio companies include Agrinnovate India, Avraham Pharmaceuticals and Chiasma. Yissum’s business partners include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.
Yissum is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem
Yissum Research Development is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem. Founded 1964 in Jerusalem, Yerushalayim, Israel, this government and university program invests in private equity and early stage ventures. It typically funds Series A, venture rounds, private equity rounds and Series B rounds. Its portfolio companies include Agrinnovate India, Avraham Pharmaceuticals and Chiasma. Yissum’s business partners include companies such as Novartis, Johnson & Johnson, Merck, IntelIntel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.
Yissum Research Development is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem. Founded 1964 in Jerusalem, Yerushalayim, Israel, this government and university program invests in private equity and early stage ventures. It typically funds Series A, venture rounds, private equity rounds and Series B rounds. Its portfolio companies include Agrinnovate India, Avraham Pharmaceuticals and ChiasmaChiasma. Yissum’s business partners include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.
Yissum Research Development is a technology transfer company in Israel that markets the inventions of the Hebrew University of Jerusalem. Founded 1964 in Jerusalem, Yerushalayim, Israel, this government and university program invests in private equity and early stage ventures. It typically funds Series A, venture rounds, private equity rounds and Series B rounds. Its portfolio companies include Agrinnovate India, Avraham Pharmaceuticals and Chiasma. Yissum’s business partners include companies such as Novartis, Johnson & Johnson, Merck, Intel, GoogleGoogle, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.